A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.
Stopped The study has been terminated due to adverse finding in a non-clinical, chronic toxicology study.
Conditions
Interventions
- DRUG: AZD0233
- DRUG: AZD0233 Placebo
Sponsor
AstraZeneca
Collaborators